| Literature DB >> 30258533 |
Ted W Johnson1, Ben Bolanos1, Alexei Brooun1, Rebecca A Gallego1, Dan Gehlhaar1, Mehran Jalaie1, Michele McTigue1, Sergei Timofeevski1.
Abstract
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that can become oncogenic by activating mutations or overexpression. Full kinetic characterization of both phosphorylated and nonphosphorylated wildtype and mutant ALK kinase domain was done. Our structure-based drug design programs directed at ALK allowed us to interrogate whether X-ray crystallography data could be used to support the hypothesis that activation of ALK by mutation occurs due to increased protein dynamics. Crystallographic B-factors were converted to normalized B-factors, which allowed analysis of wildtype ALK, ALK-C1156Y, and ALK-L1196M. This data suggests that mobility of the P-loop, αC-helix, and activation loop (A-loop) may be important in catalytic activity increases, with or without phosphorylation. Both molecular dynamics simulations and hydrogen-deuterium exchange experimental data corroborated the normalized B-factors data.Entities:
Year: 2018 PMID: 30258533 PMCID: PMC6142052 DOI: 10.1021/acsmedchemlett.8b00348
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345